Abstract
Evaluation of apolipoprotein E and α-synuclein as potential biomarkers in CSF to monitor pharmaco-therapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia (P1.9-034)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have